Skip to content

Clinical trials

Terminated Carcinoma, Non-Small-Cell Lung trials in Serbia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Status: Terminated Country / region: Serbia Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20091
20111
20132
20151
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated8

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Synta Pharmaceuticals Corp.2
Aileron Therapeutics, Inc.1
Amgen1
Hoffmann-La Roche1
Pfizer1
Pharmacyclics LLC.1
Puma Biotechnology, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung8
Lung Neoplasms3
Neoplasms3
Anemia1
Carcinoma1
Carcinoma, Large Cell1
Carcinoma, Squamous Cell1
Neoplasm Metastasis1
Pleural Effusion1
Pleural Effusion, Malignant1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.